REG - Substrate Artificial Substrate AI-Class B - Completion of delivery order under agreement

Substrate Artificial Inteligence SAAnnouncement

07/10/2024 17:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241007:nRSG2428Ha&default-theme=true

RNS Number : 2428H  Substrate Artificial Inteligence,SA  07 October 2024

 

7 October 2024

 

SUBSTRATE ARTIFICIAL INTELIGENCE SOCIEDAD ANONIMA

("Substrate AI" or the "Company")

COMPLETION OF DELIVERY ORDER UNDER AGREEMENT WITH SESPA BY DIAGXIMAG

In April 2024, the Health Service of the Principality of Asturias (SESPA)
awarded Diagximag, a subsidiary company of Cuarta División (4D) Médica,
which is in turn a subsidiary of the Company, a contract valued at
€1,400,000 for the provision of 54 state-of-the-art ultrasound machines for
Asturian public health.

Substrate AI (AQUIS: SAI/SAI.B) is pleased to announce that it has
successfully completed the delivery of these ultrasound machines.

The Directors of Substrate AI accept responsibility for this announcement.

 

 Substrate AI
 Lorenzo Serratosa                     info@substrate.ai (mailto:info@substrate.ai)

 Chairman
 First Sentinel Corporate Finance

 Corporate Advisors
 Brian Stockbridge                     +44 (0) 7858 888 007

 

About Substrate AI: Substrate AI is an artificial intelligence company based
in Spain that creates, buys and scales companies around AI in diverse sectors
such as fintech, agritech, energy, human resources, or health. All of them
sell products and services built on the bio-inspired reinforced learning
technology developed and patented by Substrate AI.

This announcement contains information which, prior to its disclosure, was
inside information as stipulated under Regulation 11 of the Market Abuse
(Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication
of this announcement via a Regulatory Information Service, this inside
information is now considered to be in the public domain.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXFLFIRISLDIIS